Exane BNP Paribas Upgrades Novartis (NVS) to Outperform
Tweet
Share
E-mailGet Alerts NVS Hot Sheet
Price: $152.25 +0.91%
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Rating Summary:
7 Buy, 14 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 21 | New: 20
Join SI Premium – FREE
Exane BNP Paribas upgraded Novartis (NYSE: NVS) from Neutral to Outperform.
For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.
Shares of Novartis closed at $59.86 yesterday.
For an analyst ratings summary and ratings history on Novartis click here. For more ratings news on Novartis click here.
Shares of Novartis closed at $59.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Northland Upgrades Astera Labs (ALAB) to Outperform, 'Right Time, Customers, and Products'
- Investec Double Upgrades Alkem Laboratories Ltd (ALKEM:IN) to Buy
- RBC Capital Upgrades CAE Inc. (CAE:CN) (CAE) to Outperform
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
